Randstad Sourceright Releases Report on Demand for Key Jobs in the US During COVID-19
This week, Randstad Sourceright released its report, “How is Key Talent in the US Impacted by COVID-19?” The report analyzes data from the Bureau of Labor Statistics, World Health Organization, job boards, career sites, and social media postings to map the demand for key jobs in the US.
The report identifies the changes in demand for key jobs across six job families between January 2019 and April 2020, one of which is chemistry (pharmaceutical R&D).
While there has been a 17% decrease in overall pharma R&D jobs from February to March, the demand for clinical research associates and trial managers has increased by 46%, making it one of the few industries that has had to increase hiring since the start of the pandemic. These were identified as the two most sought after roles in pharma R&D. It is projected that the pandemic will accelerate the shortage of talent and increase recruitment activities for these roles.
The report aims to identify the shift in demand for certain skills, which will inform employers on how to be more prepared to recruit and hire once things return to normal.
For more information, click here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
